A nurse is assessing a client who has fluid volume overload from a cardiovascular disorder. Which of the following manifestations should the nurse expect?Select one that does not apply

Correct Answer: D

Rationale: The correct answer is D: Dry mucous membranes. In fluid volume overload, the body retains excess fluid leading to symptoms such as jugular vein distension, moist crackles in the lungs, and increased heart rate due to the heart's effort to pump excess fluid. Dry mucous membranes are not expected as fluid overload usually presents with signs of fluid accumulation. Dry mucous membranes are more indicative of dehydration or hypovolemia.

Correct Answer: A

Rationale: The correct answer is A: Development of lymphomas or other cancers. Black box warnings are the most serious warnings issued by the FDA for medications. Tumor necrosis factor blockers are associated with an increased risk of developing lymphomas or other cancers due to their immunosuppressive effects. This risk is well-documented in clinical studies and post-marketing surveillance. The other choices, B, C, and D, are not typically associated with tumor necrosis factor blockers. GI bleeding is more commonly associated with NSAIDs, renal failure with certain medications like ACE inhibitors or NSAIDs, and CNS effects with medications that directly affect the central nervous system.

Correct Answer: A

Rationale: The correct answer is A: Probenecid. Probenecid is a uricosuric agent that works by increasing the excretion of uric acid in the urine, thereby reducing its levels in the blood. This helps in the treatment of gout and hyperuricemia. Allopurinol (B) and Febuxostat (C) are xanthine oxidase inhibitors that work by reducing the production of uric acid. Colchicine (D) is used to relieve gout flares by reducing inflammation and pain, but it is not a uricosuric agent.

Correct Answer: A

Rationale: The correct answer is A: Hydroxychloroquine. It is used to reduce inflammation in rheumatoid arthritis by inhibiting the immune response. Hydroxychloroquine is a disease-modifying anti-rheumatic drug (DMARD) that helps control symptoms and slow the progression of the disease. Methotrexate (B) and Leflunomide (C) are also DMARDs used in RA treatment, but they have different mechanisms of action. Adalimumab (D) is a biologic drug that targets specific proteins in the immune system and is used for more severe cases of RA.

Correct Answer: C

Rationale: The correct answer is C: Inform the client not to drive or sign legal papers for 24 hours. This is because belimumab can cause dizziness or drowsiness as a side effect, which may impair the client's ability to drive or make important decisions. A: Observing the client for at least 2 hours afterward is important for monitoring immediate reactions to the medication. B: Instructing the client about the monthly infusion schedule is important for treatment adherence but not directly related to the first dose administration. D: Ensuring emergency equipment is working and nearby is important for safety but not specific to the first dose administration.